HOWEVER, a new study out of Germany finds that high-intensity exercise puts us at risk for more than just cardiac hypertrophy.

然而，德国一项新研究显示，高强度运动不只将我们暴露在心脏肥大风险中。

This year it acquired Cardior, a German firm, whose lead drug candidate, CDR132L, works by blocking a particular miRNA in the hope of helping patients with chronic heart failure and cardiac hypertrophy (thickening and stiffening of the walls of the heart).

今年，该公司收购了德国公司 Cardior，该公司的主要候选药物 CDR132L 通过阻断特定的 miRNA 发挥作用，希望能够帮助患有慢性心力衰竭和心脏肥大（心壁增厚和变硬）的患者。